BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16357834)

  • 1. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells.
    Heidari M; Rice KL; Phillips JK; Kees UR; Greene WK
    Leukemia; 2006 Feb; 20(2):304-12. PubMed ID: 16357834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent.
    Rice KL; Kees UR; Greene WK
    Biochem Biophys Res Commun; 2008 Mar; 367(3):707-13. PubMed ID: 18073142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
    Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
    Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
    Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
    Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors.
    Rice KL; Izon DJ; Ford J; Boodhoo A; Kees UR; Greene WK
    Leuk Res; 2008 Jun; 32(6):873-83. PubMed ID: 18082256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.
    Chen E; Kwon YT; Lim MS; Dubé ID; Hough MR
    Oncogene; 2006 Sep; 25(42):5752-63. PubMed ID: 16862188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
    Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
    Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
    Riz I; Hawley RG
    Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
    Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
    Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors.
    Riz I; Lee HJ; Baxter KK; Behnam R; Hawley TS; Hawley RG
    Biochem Biophys Res Commun; 2009 Mar; 380(2):361-5. PubMed ID: 19250647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
    Rakowski LA; Lehotzky EA; Chiang MY
    PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype.
    Salvati PD; Ranford PR; Ford J; Kees UR
    Oncogene; 1995 Oct; 11(7):1333-8. PubMed ID: 7478554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satellite DNA spatial localization and transcriptional activity in mouse embryonic E-14 and IOUD2 stem cells.
    Enukashvily NI; Malashicheva AB; Waisertreiger IS
    Cytogenet Genome Res; 2009; 124(3-4):277-87. PubMed ID: 19556780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural rearrangements and insertions of dispersed elements in pericentromeric alpha satellites occur preferably at kinkable DNA sites.
    Mashkova TD; Oparina NY; Lacroix MH; Fedorova LI; G Tumeneva I; Zinovieva OL; Kisselev LL
    J Mol Biol; 2001 Jan; 305(1):33-48. PubMed ID: 11114245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor YY1 associates with pericentromeric gamma-satellite DNA in cycling but not in quiescent (G0) cells.
    Shestakova EA; Mansuroglu Z; Mokrani H; Ghinea N; Bonnefoy E
    Nucleic Acids Res; 2004; 32(14):4390-9. PubMed ID: 15316102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple negative elements contribute to repression of the HOX11 proto-oncogene.
    Brake RL; Kees UR; Watt PM
    Oncogene; 1998 Oct; 17(14):1787-95. PubMed ID: 9778044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.